The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin™) in chemoresistant ovarian cancer cells

J. A. Menendez, L. Vellon, R. Lupu

Research output: Contribution to journalArticle

26 Scopus citations

Fingerprint Dive into the research topics of 'The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin™) in chemoresistant ovarian cancer cells'. Together they form a unique fingerprint.